Clinical Trial Update: Docetaxel With or Without PI-88 in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial updating docetaxel with or without PI-88 in stage IIIB/IV non-small cell lung cancer completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• PI-88

Snippet

Sponsor: Cellxpert Biotechnology Corp. | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED